铜死亡在口腔鳞状细胞癌治疗及预后中的研究进展

doi:10.13591/j.cnki.kqyx.2024.11.014

Abstract

Abstract:

Oral squamous cell carcinoma(OSCC)is a malignant tumor with a high mortality rate, which is characterized by late diagnosis, high recurrence and metastasis rates, and poor prognosis. Cuproptosis, as a novel mode of cupric induced cell death, can inhibit the growth and proliferation of cancer cells by activating related pathways, which provides a new insight into the treatment of OSCC. This review aims to systematically introduce the mechanism of cuproptosis occurrence and development, as well as the research progress of cuproptosis in the prognosis of OSCC treatment. It provides new ideas and methods for clinical treatment.

Key words: oral squamous cell carcinoma, cuproptosis, ferredoxin 1, protein lipids, copper chelates, lncRNA, tricarboxylic acid cycle

CLC Number:

R780.2

YAO Tian, MA Yufeng. Research progress of cuproptosis in the treatment and prognosis of oral squamous cell carcinoma[J]. Stomatology, 2024, 44(11): 871-875.

Figures/Tables 1

References 45

[1]	Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxicstress[J]. Nat Chem Biol, 2019, 15(7): 681-689. doi: 10.1038/s41589-019-0291-9 pmid: 31133756
[2]	Li ZL, Cai H, Li ZQ, et al. A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody[J]. Bioact Mater, 2022, 21: 299-312.
[3]	Del Re DP, Amgalan D, Linkermann A, et al. Fundamental mechanisms of regulated cell death and implications for heart disease[J]. Physiol Rev, 2019, 99(4): 1765-1817. doi: 10.1152/physrev.00022.2018 pmid: 31364924
[4]	Tang DL, Kang R, Berghe TV, et al. The molecular machinery of regulated cell death[J]. Cell Res, 2019, 29(5): 347-364. doi: 10.1038/s41422-019-0164-5 pmid: 30948788
[5]	Vitório JG, Duarte-Andrade FF, Dos Santos Fontes Pereira T, et al. Metabolic landscape of oral squamous cell carcinoma[J]. Metabolomics, 2020, 16(10): 105. doi: 10.1007/s11306-020-01727-6 pmid: 33000429
[6]	Ge EJ, Bush AI, Casini A, et al. Connecting copper and cancer: From transition metal signalling to metalloplasia[J]. Nat Rev Cancer, 2022, 22(2): 102-113.
[7]	Cobine PA, Brady DC. Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death[J]. Mol Cell, 2022, 82(10): 1786-1787. doi: 10.1016/j.molcel.2022.05.001 pmid: 35594843
[8]	Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins[J]. Science, 2022, 375(6586): 1254-1261. doi: 10.1126/science.abf0529 pmid: 35298263
[9]	Tang DL, Chen X, Kroemer G. Cuproptosis: A copper-triggered modality of mitochondrial cell death[J]. Cell Res, 2022, 32(5): 417-418. doi: 10.1038/s41422-022-00653-7 pmid: 35354936
[10]	Duan WJ, He RR. Cuproptosis: Copper-induced regulated cell death[J]. Sci China Life Sci, 2022, 65(8): 1680-1682.
[11]	Zhao JN, Guo SC, Schrodi SJ, et al. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives[J]. Front Immunol, 2022, 13: 930278.
[12]	黄本林, 付瑞, 王宁, 等. 铜死亡与肿瘤的关系研究进展[J]. 临床误诊误治, 2022, 35(11): 112-116.
[13]	Zanoni DK, Montero PH, Migliacci JC, et al. Survival outcomes after treatment of cancer of the oral cavity(1985—2015)[J]. Oral Oncol, 2019, 90: 115-121.
[14]	Parke SC, Langelier DM, Cheng JT, et al. State of rehabilitation research in the head and neck cancer population: Functional impact vs. impairment-focused outcomes[J]. Curr Oncol Rep, 2022, 24(4): 517-532. doi: 10.1007/s11912-022-01227-x pmid: 35182293
[15]	Sha SN, Si LY, Wu XR, et al. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer[J]. Front Immunol, 2022, 13: 922780.
[16]	Song Q, Zhou R, Shu FP, et al. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer[J]. Front Immunol, 2022, 13: 958368.
[17]	Shan JS, Geng R, Zhang Y, et al. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma[J]. Comput Biol Med, 2022, 149: 105988.
[18]	Li YQ. Copper homeostasis: Emerging target for cancer treatment[J]. IUBMB Life, 2020, 72(9): 1900-1908.
[19]	Babak MV, Ahn D. Modulation of intracellular copper levels as the mechanism of action of anticancer copper complexes: Clinical relevance[J]. Biomedicines, 2021, 9(8): 852.
[20]	Guo F, Yang Z, Kulbe H, et al. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation[J]. Biomed Pharmacother, 2019, 118: 109371.
[21]	Xiong K, Zhou Y, Karges J, et al. Autophagy-dependent apoptosis induced by apoferritin-Cu(Ⅱ) nanoparticles in multidrug-resistant colon cancer cells[J]. ACS Appl Mater Interfaces, 2021, 13(33): 38959-38968.
[22]	Machado JF, Sequeira D, Marques F, et al. New copper(I)complexes selective for prostate cancer cells[J]. Dalton Trans, 2020, 49(35): 12273-12286. doi: 10.1039/d0dt02157a pmid: 32839796
[23]	Chen SY, Chang YL, Liu ST, et al. Differential cytotoxicity mechanisms of copper complexed with disulfiram in oral cancer cells[J]. Int J Mol Sci, 2021, 22(7): 3711.
[24]	Kahlson MA, Dixon SJ. Copper-induced cell death[J]. Science, 2022, 375(6586): 1231-1232. doi: 10.1126/science.abo3959 pmid: 35298241
[25]	林锦贤, 王攀, 吴欣谋, 等. 铜稳态失调诱导调节性细胞死亡及其调控的研究进展[J]. 江苏大学学报(医学版), 2022, 32(4): 306-317.
[26]	Thongnuanjan P, Soodvilai S, Chatsudthipong V, et al. Fenofibrate reduces cisplatin-induced apoptosis of renal proximal tubular cells via inhibition of JNK and p38 pathways[J]. J ToxicolSci, 2016, 41(3): 339-349.
[27]	Ryumon S, Okui T, Kunisada Y, et al. Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma[J]. Oncol Rep, 2019, 42(6): 2611-2621. doi: 10.3892/or.2019.7367 pmid: 31638244
[28]	Xiong C, Ling H, Hao Q, et al. Cuproptosis: P53-regulated metabolic cell death?[J]. Cell Death Differ, 2023, 30(4): 876-884.
[29]	Suzuki S, Tanaka T, Poyurovsky MV, et al. Phosphate-activated glutaminase(GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species[J]. Proc Natl Acad Sci USA, 2010, 107(16): 7461-7466.
[30]	Tajan M, Hock AK, Blagih J, et al. A role for p53 in the adaptation to glutamine starvation through the expression of SLC1A3[J]. Cell Metab, 2018, 28(5): 721-736, e6. doi: S1550-4131(18)30448-0 pmid: 30122553
[31]	Chung CYS, Posimo JM, Lee SM, et al. Activity-based ratiometric FRET probe reveals oncogene-driven changes in labile copper pools induced by altered glutathione metabolism[J]. Proc Natl Acad Sci USA, 2019, 116(37): 18285-18294.
[32]	Jiang L, Kon N, Li TY, et al. Ferroptosis as a p53-mediated activity during tumour suppression[J]. Nature, 2015, 520(7545): 57-62.
[33]	Miller KD, Nogueira L, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2019[J]. CA Cancer J Clin, 2019, 69(5): 363-385.
[34]	Bugshan A, Farooq I. Oral squamous cell carcinoma: Metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis[J]. F1000 Research, 2020, 9: 229.
[35]	Wan LL, Gu DS, Li PZ. LncRNA SNHG16 promotes proliferation and migration in laryngeal squamous cell carcinoma via the miR-140-5p/NFAT5/Wnt/β-catenin pathway axis[J]. Pathol Res Pract, 2022, 229: 153727.
[36]	Yang LQ, Yu JL, Tao L, et al. Cuproptosis-related lncRNAs are biomarkers of prognosis and immune microenvironment in head and neck squamous cell carcinoma[J]. Front Genet, 2022, 13: 947551.
[37]	Zhou LQ, Shen JX, Zhou JY, et al. The prognostic value of m6A-related LncRNAs in patients with HNSCC: Bioinformatics analysis of TCGA database[J]. Sci Rep, 2022, 12(1): 579.
[38]	Li JF, Chen SY, Liao YX, et al. Arecoline is associated with inhibition of cuproptosis and proliferation of cancer-associated fibroblasts in oral squamous cell carcinoma: A potential mechanism for tumor metastasis[J]. Front Oncol, 2022, 12: 925743.
[39]	Roma-Rodrigues C, Mendes R, Baptista PV, et al. Targeting tumor microenvironment for cancer therapy[J]. Int J Mol Sci, 2019, 20(4): 840.
[40]	Pilankar A, Singhavi H, Raghuram GV, et al. A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study(RESCU 004)[J]. Front Oncol, 2022, 12: 1000957.
[41]	Pal K, Raghuram GV, Dsouza J, et al. A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice[J]. Sci Rep, 2022, 12(1): 17209. doi: 10.1038/s41598-022-21388-w pmid: 36241685
[42]	Gong J, Chehrazi-Raffle A, Reddi S, et al. Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: A comprehensive review of registration trials and future considerations[J]. J Immunother Cancer, 2018, 6(1): 8. doi: 10.1186/s40425-018-0316-z pmid: 29357948
[43]	Li XG, Zhou WB, Zhu C, et al. Multi-omics analysis reveals prognostic and therapeutic value of cuproptosis-related lncRNAs in oral squamous cell carcinoma[J]. Front Genet, 2022, 13: 984911.
[44]	Patel SP, Kurzrock R. PD-L1 expression as a predictive biomarker in cancer immunotherapy[J]. Mol Cancer Ther, 2015, 14(4): 847-856. doi: 10.1158/1535-7163.MCT-14-0983 pmid: 25695955
[45]	Voli F, Valli E, Lerra L, et al. Intratumoral copper modulates PD-L1 expression and influences tumor immune evasion[J]. Cancer Res, 2020, 80(19): 4129-4144. doi: 10.1158/0008-5472.CAN-20-0471 pmid: 32816860

Research progress of cuproptosis in the treatment and prognosis of oral squamous cell carcinoma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 45

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	XIONG Ke, ZHANG Hao, HU Tuqiang. Experimental study on emodin regulating the proliferation of oral squamous cell carcinoma cells through autophagy [J]. Stomatology, 2024, 44(8): 602-608.
[2]	YI Jie, DING Yujie, SHAN Yufei, GU Jiaqi, SUN Zhida. Neutrophil extracellular traps regulating the development and prognosis of oral squamous cell carcinomas [J]. Stomatology, 2024, 44(7): 500-517.
[3]	SUN Xinyi, PAN Yuetong, LU Xinyue, LYU Zhongjing, YUAN Jian, LI Jiafeng, SHI Huan. Analysis of PTK7 expression in oral squamous cell carcinoma and its biological function [J]. Stomatology, 2024, 44(4): 268-275.
[4]	WANG Yapei, LUO Yuchun, LIU Wei, LIU Chang, TANG Wanrong. Effect of EP300 on the proliferation and migration of oral squamous carcinoma cells [J]. Stomatology, 2024, 44(2): 88-93.
[5]	XU Yiping, HUANG Jialing, LIU Zhongbin, YANG Kun, GE Song. Research progress of the relationship between Fusobacterium nucleatum and oral squamous cell carcinoma [J]. Stomatology, 2023, 43(6): 546-551.
[6]	HU Haiyan, GAO Teng, ZHU Zai'ou, DING Xu, WU Yunong, SONG Xiaomeng. Study on the role of CMTM4 in oral squamous cell carcinoma and its mechanism [J]. Stomatology, 2023, 43(6): 481-487.
[7]	YANG Yuemei,SONG Xiaomeng,WU Yunong. Promotion of cell proliferation by Notch1^P1641S mutation through PI3K/Akt activation in OSCC [J]. Stomatology, 2023, 43(5): 393-399.
[8]	XIAO Tao, HE Yijia, ZHU Yaoping, HAO Fengyao, CHEN Yan, WANG Zhiyong. Study on the mechanism of VEGF inducing tolerogenic dendritic cells in oral squamous cell carcinoma [J]. Stomatology, 2023, 43(3): 204-211.
[9]	TONG Xuexi, ZHAO Gang. In vitro study on miR-191-5p targeting TJP1 to regulate the proliferation, invasion and migration of Cal-27 cells [J]. Stomatology, 2023, 43(11): 981-988.
[10]	XIAO Jinzhi, YU Wei, ZHANG Hao. Berberine hydrochloride inhibits the proliferation of oral squamous cell carcinoma by regulating autophagy [J]. Stomatology, 2023, 43(10): 889-893.
[11]	MA Ping, CHENG Luyao, JIN Wulong, WANG Ning, ZHAI Rongping. Expression level and biological function of NCAPD2 in oral squamous cell carcinoma [J]. Stomatology, 2022, 42(8): 688-693.
[12]	HOU Yiming, LI Na, YU Wenqian, CHEN Lei. Research progress of histone modification in oral squamous cell carcinoma [J]. Stomatology, 2022, 42(7): 650-654.
[13]	WANG Jinxin, YI Jie, DING Yujie, ZHONG Yi, SUN Zhida. Expression and role of Claudin-7 in oral squamous cell carcinoma [J]. Stomatology, 2022, 42(7): 604-608.
[14]	GUO Zhichen, JING Sili, HU Xiaoyi, ZHANG Zhou, CUI Hao, NA Sijia. Effect of smoking and drinking exposure history on prognosis of patients with oral squamous cell carcinoma at different ages [J]. Stomatology, 2022, 42(6): 521-524.
[15]	QIAN Weixiang, WU Yanfei, YANG Weiping, SHAO Li. Effects of miR-127-3p on proliferation, migration and Zwint-1 gene expression of oral squamous cell carcinoma cells [J]. Stomatology, 2022, 42(2): 117-124.